The PMCB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PMCB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PMCB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
![]() |
View PMCB Detailed Price Forecast - CNN Money | ![]() |
View PMCB Detailed Summary - Google Finance |
![]() |
View PMCB Detailed Summary - Yahoo! Finance | ![]() |
View PMCB Stock Research & Analysis - Zacks.com |
![]() |
View PMCB Trends & Analysis - Trade-Ideas | ![]() |
View PMCB Major Holders - Barrons |
![]() |
View PMCB Call Transcripts - NASDAQ | ![]() |
View PMCB Breaking News & Analysis - Seeking Alpha |
![]() |
View PMCB Annual Report - CompanySpotlight.com | ![]() |
View PMCB OTC Short Report - OTCShortReport.com |
![]() |
View PMCB Fundamentals - TradeKing | ![]() |
View PMCB SEC Filings - Bar Chart |
![]() |
View Historical Prices for PMCB - The WSJ | ![]() |
View Performance/Total Return for PMCB - Morningstar |
![]() |
View the Analyst Estimates for PMCB - MarketWatch | ![]() |
View the Earnings History for PMCB - CNBC |
![]() |
View the PMCB Earnings - StockMarketWatch | ![]() |
View PMCB Buy or Sell Recommendations - MacroAxis |
![]() |
View the PMCB Bullish Patterns - American Bulls | ![]() |
View PMCB Short Pain Metrics - ShortPainBot.com |
![]() |
View PMCB Stock Mentions - StockTwits | ![]() |
View PMCB Stock Mentions - PennyStockTweets |
![]() |
View PMCB Stock Mentions - Twitter | ![]() |
View PMCB Investment Forum News - Investor Hub |
![]() |
View PMCB Stock Mentions - Yahoo! Message Board | ![]() |
View PMCB Stock Mentions - Seeking Alpha |
![]() |
View Insider Transactions for PMCB - SECform4.com | ![]() |
View Insider Transactions for PMCB - Insider Cow |
![]() |
View PMCB Major Holdings Summary - CNBC | ![]() |
View Insider Disclosure for PMCB - OTC Markets |
![]() |
View Insider Transactions for PMCB - Yahoo! Finance | ![]() |
View Institutional Holdings for PMCB - NASDAQ |
![]() |
View PMCB Stock Insight & Charts - FinViz.com | ![]() |
View PMCB Investment Charts - StockCharts.com |
![]() |
View PMCB Stock Overview & Charts - BarChart | ![]() |
View PMCB User Generated Charts - Trading View |
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
Posted on Wednesday November 15, 2023
LAS VEGAS, November 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) ("Femasys"), a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in-office, accessible solutions, including a lead late-stage product candidate and innovative therapeutic and diagnostic products. This is the Company’s first investment in externally dev
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
Posted on Wednesday November 15, 2023
- $6.85 million upfront investment provides $23 million total cash runway into second half 2025 - - Financing allows for focused commercial team to bring Femasys’ infertility-related products to women in the U.S. - - Additional financing supports the advancement of Femasys’ lead product candidate, FemBloc® for permanent birth control, to initial clinical data readout - ATLANTA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unme
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
Posted on Tuesday October 31, 2023
LAS VEGAS, October 31, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") provides an update on its investigation of its Cell-in-a-Box technology and initial next steps in development. Following a comprehensive scientific review of amassed data, the Company is in the process of requesting a meeting with the U.S. Food and Drug Administration (FDA) for guidance on further development of the technology. The meeting is expected to occur during the first quarter of 2024. In
PharmaCyte Biotech Announces Final Results of Tender Offer
Posted on Thursday June 15, 2023
LAS VEGAS, June 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") today announces the final results of its previously announced tender offer to acquire up to 7,750,000 million shares of the Company’s common stock, par value $0.001 per share, at a price of $3.25 per share in cash, less any applicable withholding taxes and without interest. The tender offer expired one minute after 11:59 p.m. on June 9, 2023, and was funded entirely through the Company’s cash on han